Series A Therapeutics Companies

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

InHandPlus is developing solutions to improve the way we take our prescribed medications.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Upkara operates as a biotechnology company that specializes in developing biopreservation technologies.

SpectrumAi is modernizing and democratizing access to high-quality autism treatment.

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Switch Therapeutics is a biotech company that develops RNAi therapies.

Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Find therapeutics is operator of a drug discovery and development company intended to emerge with a new therapeutic modality.

Neumirna Therapeutics is a pharmaceutical company that develops therapeutics for the treatment of neurological diseases.

Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.

Barologics develops disruptive technology to treat hypertension through closed-loop stimulation.

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

Aradigm Health platform enables access to next generation of transformative therapies—cell and gene therapies (CGTs).

TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.

Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.

RxCell is a biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC).

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.